The 12th meeting of the 11th board of directors and the 11th meeting of the 10th board of supervisors held to review and approve the annual work report and other relevant proposals
Release time:
2023-04-21
General Manager's report pointed out that in 2022, my country's macroeconomic policy will adhere to the general tone of seeking progress while maintaining stability. The annual GDP was 121.02 trillion billion yuan, an increase of 3.0 percent over last year (data source: National Bureau of Statistics). Centering on the general policy of "reform, breakthrough, innovation and development", the company strives to maintain the orderly development of various production and operation work, achieving operating income of 3.56 billion yuan for the whole year, a decrease of 6.43 percent over the same period last year, and net profit attributable to shareholders of 0.288 billion yuan, a decrease of 68.86 percent over the same period last year. By the end of 2022, the company's total assets were 7.321 billion billion yuan, up 4.22 percent year-on-year, and the net assets attributable to shareholders of listed companies were 5.186 billion billion yuan, down 0.41 percent year-on-year.
2022
, the company's industrial chain extension war made new progress. The company set up Yunnan Jianfeng New Building Materials Co., Ltd. to promote its aggregate, machine sand and other projects in an orderly manner, and Yunnan Jianfeng invested 0.133 billion yuan to increase the capital of its subsidiary Jianfeng Exhibition, making it a holding enterprise of the company, and the company's cement business sector has been further developed.
Facing the unfavorable external environment, the company's cement companies continue to implement benchmarking and refined management, steadily implement various technical reforms, strictly control production costs, strive to overcome the pressure of declining demand, and actively expand the sales market. Daye Peak has improved the overall production capacity of the kiln system through technical transformation and operation process optimization of grate cooler, packaging machine and kiln cylinder, combined with the use of MES system for optimal parameter traceability. Actively develop new agents, open up new markets, strengthen cooperation with large enterprises, undertake key projects, effectively cope with the overall weak cement market and maintain the balance of production and sales; vigorously promote the construction of green mines and green factories, and successfully entered the list of national green factories in 2022. Yunnan Jianfeng has strengthened the technological transformation of energy saving and consumption reduction, reformed the kiln head sealing device, grate cooler and other equipment, and improved the kiln output. The dust collector at the bottom of the cement blending warehouse has been added, and the feeding device of the roller press has been reformed, effectively improving the production site environment. Actively implement the brand strategy, adhere to the "direct sales + agent" dual-track sales model, while effectively reducing the sales cost while maintaining the advantages of multi-channel sales. Huang Ping Jianfeng actively studied, explored and applied advanced technology to tackle key problems. Through the transformation of the cone under the decomposition furnace to reduce negative pressure fluctuation, replace the high-temperature feed lock valve, and increase the snowman pushing device of the grate cooler, the stability of the equipment has been improved. Facing the unfavorable demand situation, it actively undertakes key projects externally and strengthens the business skills training of the marketing team internally, with Kaili and Huang Ping as the core markets, maintain the leading sales of the same type of kiln line in the region.2022
, the company's pharmaceutical sector technical reform and engineering construction continued to advance, innovation and research and development to make new progress. Jianfeng Pharmaceutical's annual production of 2 billion tablets of solid preparations (international project) has completed the completion acceptance of construction projects, equipment installation and debugging, certified product registration batch production, completed the human bioequivalence test, submitted registration materials, and entered the waiting stage of cGMP application for certification; jinxi Production Base has completed the completion and acceptance of the technical transformation project of bulk drugs, completed the installation and debugging of the newly added RTO incineration treatment facilities, completed the automatic transformation of the packaging equipment of freeze-dried powder injection and solid preparation production line, and completed the transformation of the refrigeration system of the raw material workshop and the comprehensive preparation building. The construction of the single-dose eye drop production line of Jianfeng Pharmaceutical has also been basically completed and has entered the stage of product stability inspection. The 205 and 206 workshops of Anhui Xinbeika Phase II Project have been completed and put into trial production. The chlorine dioxide workshop has completed the information control transformation and improved the safety guarantee level. The technical renovation project of Moxi Xiaohuan and pharmaceutical intermediates in Jianfeng Beika 102 Workshop has been completed and put into trial operation. The 203, 205 and 206 workshops have been completed and have entered the stage of production plan review. Jianfeng Pharmaceutical and its subsidiaries further increased investment in research and development, continued to promote the phase I clinical trials of the new anti-tumor drug DPT and JFAN-1001 project, and completed the application for production registration of several products such as fluprost eye drops, single-dose sodium hyaluronate eye drops, and mycophenolate mofetil capsules. At present, 11 drugs (including consistency evaluation) have been submitted to the State Drug Administration for production registration.
On the same day, the company also held the 11th meeting of the 10th Board of Supervisors, and reviewed and approved 5 related reports and proposals including the 2022 Board of Supervisors Report of the company. (residual fruit)
More information
Teachers and Students of Zhejiang Gongshang University Visit Peak Health
News from our newspaper On the morning of June 9, a group of 18 teachers and students from Zhejiang Gongshang University came to Jianfeng Health for a visit and discussion, and conducted research on the establishment of Zhejiang Gongshang University Food Industrialization Research Institute in Jinhua. The leader of this visit is Professor Song Guanglei from the School of Food and Biological Engineering, Zhejiang Gongshang University. The teachers and students are mainly from the School of Food and Engineering, specializing in food science, food safety, biochemical and biotechnology, focusing on extraction and separation, functional activity and The research of functional food, in addition to the professor of the Department of E-commerce of the School of Management Engineering and E-commerce. Chen Daiyou, general manager of Jianfeng Health, Li Wende, deputy general manager, and relevant personnel from R & D, quality management, administrative personnel and other departments attended the forum. Li Wende introduced the basic situation, technical production level, scientific and technological research and development characteristics of Jianfeng Health Company in the form of PPT, as well as the relevant policies of Jinhua Municipal Government on talent introduction. Chen Daiyou focused on the development vision of Jianfeng Health Technology and the construction of scientific and technological talents, and welcomed graduate students from the Industrial and Commercial University to join the team of Jianfeng Health after graduation. Professor Song Guanglei fully affirmed the software and hardware facilities and humanistic management of Jianfeng Health Company. He said that most of the teachers and students who came to visit this time were professional in line with the industry of Jianfeng Health Company. The two sides could carry out in-depth cooperation in product development, technology upgrading and talent reserve. Fourteen graduate students also introduced their respective situations and study and research directions. After the symposium, the teachers and students visited the health company's testing center, R & D laboratory and plant extraction workshop with great interest.
2020
07-31
Trial operation of large pharmacy micro-mall
The construction of the micro-mall of Jianfeng Pharmacy is basically ready at present. On June 17, Shuangxi and Donglai chain stores took the lead in the trial operation of the micro-mall. At present, online consumption through computers and mobile phones has become a way of life in China. In particular, various software represented by WeChat covers more than 90% of smart phones, and has many functions such as information exchange and online payment. It is a new type of shopping system based on WeChat platform, using mobile Internet technology to realize the integration of online and offline marketing. At present, there are more than 1000 kinds of commodities on the shelves of the micro-mall of Jianfeng pharmacy, mainly OTC commodities of over-the-counter drugs, which are basically synchronized with pharmacies. Customers only need to pay attention to the public number of Jianfeng Pharmacy and enter the micro-mall to collect coupons through the "online drug purchase" on the public number page. They can find the required drugs on the mobile phone to purchase and pay for them. The delivery method can be delivered to the door or the store can pick them up by itself. The purchase of drugs through the micro-mall is not only convenient and fast, but also can reduce the phenomenon of queuing in the store. According to reports, the opening of the micro mall by the big pharmacy is to expand the new service model and provide more and better extended services to the masses. Prior to this, the WeChat public number of the large pharmacy has already made a useful attempt to push health information, and the operation of the micro-mall will further provide users with new channels for seeking medical advice. While further improving the micro-mall system, the large pharmacy will add "online pharmacists" and other service items to provide users with real-time consulting services such as medication guidance, drug purchase recommendation, health care knowledge and so on in the form of voice or text. (Tang Wenshu)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-30
Spike Health gets patent grants
Recently, Jianfeng Health Technology Company's invention patent "a low-temperature and low-pressure freeze-drying method for notoginseng chewable tablets" won a patent subsidy from Jinhua Science and Technology Bureau in 2017. In order to encourage invention and creation, promote independent innovation, promote the development of patented technology and products, and speed up the transformation of patent achievements, Jinhua Science and Technology Bureau gives invention patent subsidies to enterprises within its jurisdiction every year. Patent subsidies are declared once a year. After authorization, each domestic invention patent can receive a subsidy of 40000 yuan, including 20000 yuan in Jinhua City and 20000 yuan in the district. The invention patent of spike health "a low-temperature and low-pressure freeze-drying method of notoginseng chewable tablets" obtains notoginseng chewable tablets by washing, slicing and other pretreatment of fresh notoginseng main roots, then placing them in a vacuum dryer for vacuum freeze-drying. As the top high and new technology in the field of dehydration products, the whole freeze-drying process is carried out at low temperature, which avoids the quality deterioration reactions such as oxidation of active ingredients, destruction of volatile oil and other heat-sensitive substances in the traditional drying process. It can maximize the retention of various nutrients and active substances of medicinal materials and perfectly reproduce its initial type, color and taste, it has the characteristics of light weight, fast rehydration, convenient consumption and long storage period. The actual effect, appearance and color are basically the same as those of fresh Panax notoginseng. The effective ingredients are about 50% higher than those of products processed by traditional processes such as drying and drying. It is understood that the 2017 Jinhua patent subsidy of 20000 yuan obtained by Jianfeng Health is currently in place, and the application of patent subsidy in Wucheng District is in progress. (Xu Feng)
2020
07-31
On May 27, the Party Committee of the Group Company held a branch secretary meeting to comprehensively review and summarize the Party building work of the Company in 2016 and sign the responsibility book for the management of Party building work objectives in 2017. At the meeting, Qin xuping, member of the party Committee of the group company and director of the party-mass work department, made a comprehensive summary of the company's party building work in 2016, put forward the 2017 work plan, and conveyed the "key points of party building work in the city's two new organizations in 2017" issued by the two new working committees of Jinhua municipal party Committee, and the spirit of the speech made by the relevant leaders of the municipal party Committee at the recent meeting of the city's two new working committee, this paper explains the "ten questions" of the two new grass-roots party organizations, the "ten questions" of Party members and some problems that need attention in the process of Party member development. Members of the party committee of the group company, secretaries of grass-roots party committees and branch secretaries expressed their views and conducted extensive exchanges on such topics as how to deepen the "two learning and one doing", further play the role of party organizations in the process of enterprise operation and management, and how to do a good job in organizational construction in 2017. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, on behalf of the party committee of the group, signed the 2017 party building work target management responsibility letter with the heads of the party organizations of various professional companies and directly affiliated enterprises. In his speech at the meeting, Jiang Xiaomeng said that the Politburo meeting of the CPC Central Committee held on the 26th reviewed and approved the "Decision on Amending the Regulations on the Inspection Work of the Communist Party of China" and other reports, which is a major measure to further implement the provisions of the party constitution and strengthen internal party supervision. Specific to the internal party building work of the enterprise, all cadres and party members should earnestly study relevant policies and documents, and earnestly understand the spirit of the central government
2020
07-31